Long-Term, Observational, Global Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition TherapiesFirst published 19/02/2025 Last updated 24/06/2025 EU PAS number: EUPAS1000000478StudyOngoing